Emergence of Natural Killer Cell Large Granular Lymphocytes during Gilteritinib Treatment in Acute Myeloid Leukemia with FLT3-ITD Mutation

As the potent, selective Fms-Like Tyrosine Kinase 3 (FLT3) inhibitor gilteritinib has only been approved for use for a few years, its efficacy and complications remain incompletely understood. We herein report an elderly patient with FLT3 internal tandem duplications (FLT3-ITD) mutated acute myeloid...

Descripció completa

Dades bibliogràfiques

Autors principals:	Shintaro Izumi, Yosuke Minami, Shinichi Masuda, Yoshikazu Utsu, Emiko Sakaida, Nobuyuki Aotsuka
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2020-09-01
Col·lecció:	Reports
Matèries:	acute myeloid leukemia (AML) Fms-Like Tyrosine Kinase 3 internal tandem duplications (FLT3-ITD) mutation Gilteritinib natural killer cell large granular lymphocytes (NK-LGL)
Accés en línia:	https://www.mdpi.com/2571-841X/3/3/25
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!